<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417715</url>
  </required_header>
  <id_info>
    <org_study_id>HN-0008</org_study_id>
    <nct_id>NCT01417715</nct_id>
  </id_info>
  <brief_title>Endomicroscopy for Assessment of Mucosal Healing</brief_title>
  <official_title>Advanced Endoscopic Imaging Using Endomicroscopy for Assessment of Mucosal Healing in IBD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inflammatory bowel disease (IBD) encompasses two major forms of chronic intestinal disorders,
      Crohn's disease and ulcerative colitis (UC). Diagnosis is based on several macroscopic and
      histologic features including patterns of inflammation, crypt abscesses and granulomas.
      Confocal laser endomicroscopy (CLE) is rapidly emerging as a valuable tool for
      gastrointestinal endoscopic imaging, enabling the endoscopist to obtain an &quot;optical biopsy&quot;
      of the gastrointestinal mucosa during the endoscopic procedure.

      The main objective of this study is to determine endomicroscopic features of mucosal healing
      in patients with IBD.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mucosal healing</measure>
    <time_frame>up to three years</time_frame>
    <description>We will determine endomicroscopic features of mucosal inflammation (e.g. goblet cell depletion, leackage, microvessel density) in IBD in order to establish a new endoscopic classification of mucosal healing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histologic correlation</measure>
    <time_frame>up to three years</time_frame>
    <description>Comparison of clinical and histopathological data with endoscopic findings to evaluate mucosal healing as a parameter of remission and relapse in patients with IBD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapeutic effect</measure>
    <time_frame>up to three years</time_frame>
    <description>We will evaluate the effect of different therapeutic strategies (eg. anti-TNF treatment) on characteristics of mucosal healing (e.g. goblet cell depletion, microvessels, leakage).</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Crohn´s Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Crohn´s disease - active</arm_group_label>
    <description>Patients with Crohn´s disease in the active phase.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crohn´s disease - quiescent</arm_group_label>
    <description>Patients with Crohn´s disease in the quiescent phase.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ulcerative colitis - active</arm_group_label>
    <description>Patients with ulcerative colitis in the active stage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ucerative colitis - quiescent</arm_group_label>
    <description>Patients with ulcerative colitis in the quiescent stage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endomicroscopy</intervention_name>
    <description>Patients will undergo advanced endoscopic imaging using endomicroscopy. Findings will be compared to histopathological and clinical results.</description>
    <arm_group_label>Crohn´s disease - active</arm_group_label>
    <arm_group_label>Crohn´s disease - quiescent</arm_group_label>
    <arm_group_label>Ulcerative colitis - active</arm_group_label>
    <arm_group_label>Ucerative colitis - quiescent</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Crohn´s disease and ulcerative colitis in the active and quiescent phase of
        the disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Age 18-85 years

          -  Ability of subjects to understand character and individual consequences of clinical
             trial

          -  Subjects undergoing colonoscopy

        Exclusion Criteria:

          -  Inability to provide written informed consent

          -  Severe Coagulopathy (Prothrombin time &lt; 50% of control, Partial thromboplastin time &gt;
             50 s)

          -  Pregnancy or breast feeding

          -  Active gastrointestinal bleeding

          -  Residing in institutions (e.g. prison)

          -  Known allergy against fluorescein

          -  Proctocolectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Neumann, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine I, University of Erlangen-Nuremberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus F. Neurath, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine I, University of Erlangen-Nuremberg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helmut Neumann, Professor</last_name>
    <phone>+4991318535000</phone>
    <email>helmut.neumann@uk-erlangen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markus F. Neurath, Professor</last_name>
    <phone>+4991318535000</phone>
    <email>markus.neurath@uk-erlangen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Erlangen-Nuremberg</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helmut Neumann, Professor</last_name>
      <phone>+4991318535000</phone>
      <email>helmut.neumann@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Helmut Neumann, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2011</study_first_submitted>
  <study_first_submitted_qc>August 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Helmut Neumann</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

